Brachytherapy versus surgery in carcinoma of tonsillar fossa and/or soft palate: Late adverse sequelae and performance status: Can we be more selective and obtain better tissue sparing?

International Journal of Radiation Oncology Biology Physics

Volumn 59, Issue 3, 2004, Pages 713-724

  Levendag, Peter ^a   Nijdam, Wideke ^a   Noever, Inge ^a   Schmitz, Paul ^a   Van De Pol, Marjan ^a   Sipkema, Dick ^a   Braat, Cora ^a   De Boer, Maarten ^a   Jansen, Peter ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Brachytherapy; Functional outcome; Late side effects; Performance status scale; Soft palate; Squamous cell carcinoma; Surgery; Survival; Tonsillar fossa; Trismus; Tumor control; Ulceration; Xerostomia

Indexed keywords

CARCINOGENS; ONCOLOGY; PATIENT TREATMENT; RADIOTHERAPY; REGRESSION ANALYSIS; TUMORS;

BRACHYTHERAPY; TONSILLAR FOSSA; TUMOR CONTROL;

SURGERY;

IRIDIUM 192;

ADULT; AGED; ARTICLE; BEAM THERAPY; BRACHYTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; DIET; DYSPHAGIA; EATING; FEMALE; FOLLOW UP; GENDER; HUMAN; IATROGENIC DISEASE; INTERMETHOD COMPARISON; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NECK CANCER; NECK DISSECTION; NURSE; PAIN; PATIENT CARE; PERFORMANCE; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RADIATION DOSE; REGRESSION ANALYSIS; SCORING SYSTEM; SOFT PALATE; SPEECH; STATISTICAL SIGNIFICANCE; TONSIL CARCINOMA; TRISMUS; ULCER; VISUAL ANALOG SCALE; XEROSTOMIA;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BRACHYTHERAPY; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; PALATAL NEOPLASMS; PALATE, SOFT;

EID: 2442548154     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2003.11.032     Document Type: Article

References (20)

1. Leemans C.R., Engelbrecht W.J., Tiwari R.M., et al. Carcinoma of the soft palate and anterior tonsillar pillar. Laryngoscope. 104:1994;1477-1481
2. O'Sullivan B., Warde P., Grice B., et al. The benefits and pitfalls of ipsilateral radiotherapy in carcinoma of the tonsillar region. Int J Radiat Oncol Biol Phys. 51:2001;332-342
3. Withers H.R., Peters L.J., Taylor J.M.G., et al. Local control of carcinoma of the tonsil by radiation therapy An analysis of patterns of fractionation in nine institutions. Int J Radiat Oncol Biol Phys. 33:1995;549-562
4. Levendag P.C., Schmitz P.I.M., Jansen P.P., et al. Fractionated high-dose-rate and pulsed-dose-rate brachytherapy First clinical experience in squamous cell carcinoma of the tonsillar fossa and soft palate. Int J Radiat Oncol Biol Phys. 38:1997;497-506
5. Mazeron J.J., Belkacemi Y., Simon J.M., et al. Place of iridium 192 implantation in definitive irradiation of faucial arch squamous cell carcinomas. Int J Radiat Oncol Biol Phys. 27:1993;251-257
6. Pernot M., Malissard L., Hoffstetter S. Influence of tumoral, radiobiological, and general factors on local control and survival of series of 361 tumors of the velotonsillar area treated by exclusive irradiation (external beam irradiation + brachytherapy or brachytherapy alone). Int J Radiat Oncol Biol Phys. 30:1994;1051-1057
7. Fu K.K., Pajak T.F., Trotti A., et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation for head and neck squamous cell carcinomas First report of RTOG 9003. Int J Radiat Oncol Biol Phys. 48:2000;7-16
8. Pignon J.P., Bourhis J., Domenge C., et al. Meta-analysis of Chemotherapy on Head and Neck Cancer (MACH-NC) Collaborative Group. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma Three meta-analyses of updated individual data. Lancet. 355:2000;949-955
9. Bourhis J, Syz N, Overgaard J, et al. Conventional versus modified fractionated radiotherapy: Meta-analysis based on individual data of patients with head and neck squamous cell carcinoma (HNSCC) [Abstract]. ESTRO Conference, Prague, September 17-21, 2002. Radiother Oncol 2002;64(Suppl. 1)
10. Withers H.R., Peters L.J., Taylor J.M.G., et al. Late normal tissue sequelae from radiation therapy for carcinoma of the tonsil Patterns of fractionation, study of radiobiology. Int J Radiat Oncol Biol Phys. 33:1995;563-568
11. List M.A., Stracks J., Colangelo L., et al. How do head and neck cancer patients prioritize treatment outcomes before initiating treatment. J Clin Oncol. 18:2000;877-884
12. List M., Ritter-Ster C., Lansky S. A performance status scale for head and neck cancer patients. Cancer. 66:1990;564-569
13. Sobin L.H., Wittekind C.H. TNM classification of malignant tumours. 5th ed:2002;Wiley-Liss, New York. p. 33-37
14. International Commission on Radiation Units and Measurements. ICRU Report 50: Prescribing, recording and reporting photon beam therapy. 1993;ICRU Publications, Bethesda
15. Wijers O.B., Levendag P.C., Braaksma M.M.J. Patients with head and neck cancer cured by radiation therapy A survey of the dry mouth syndrome in long-term survivor. Head Neck. 24:2002;737-747
16. Levendag PC, Braaksma MJ, Coche E, et al. Rotterdam and Brussels CT-based neck nodal delineation compared to the surgical levels as defined by the American Academy of Otolaryngology-Head and Neck Surgery. Int J Radiat Oncol Biol Phys 2004;58:113-123
17. Nowak P.J., Wijers O.B., Levendag P.C. A three-dimensional CT-based target definition for elective irradiation of the neck. Int J Radiat Oncol Biol Phys. 45:1999;33-39
18. Wijers O.B., Levendag P.C., Tan T., et al. A simplified CT-based definition of the lymph node levels in the node negative neck. Radiother Oncol. 52:1999;35-42
19. Grégoire V., Levendag P.C., Ang K.K., et al. Brussels/Rotterdam CT-based consensus protocol regarding NO neck. Radiother Oncol. 69:2003;227-236
20. Nijdam WM, Levendag PC, Noever I, et al. Cost analysis comparing brachytherapy versus surgery for primary carcinoma of the tonsillar fossa and/or soft palate. Int J Radiat Oncol Biol Phys 2004;59:488-494